Canada· CA-DIN-02327813
GALLIUM (GA67) CITRATE INJECTION
A gallium (67ga) citrate product containing gallium citrate ga 67, registered in Canada by CURIUM CANADA INC. The same ATC class is registered in 7 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Gallium (67ga) citrate is registered in 7 of 19 countries.
Countries holding a registration under ATC V09HX01 (gallium (67ga) citrate), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 3 of them publish a price we can compare per daily dose
Gallium (67ga) citrate · ATC V09HX01
7 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- GALLIUM CITRATE GA 67
- Manufacturer
- CURIUM CANADA INC
- Country
- Canada (CA)
- ATC code
- V09HX01
- ATC class
- Gallium (67Ga) citrate
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Gallium (67ga) citrate in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomGallium [Ga-67] citrate 123MBq/3.3ml solution for injection vialsCurium Pharma UK Ltd
- CzechiaGALLIUM (67GA) CITRATE INJECTIONCurium Netherlands B.V., Petten
- SpainCITRATO DE GALIO (67GA) CIS BIO INTERNATIONAL 74 MBq/ml SOLUCION INYECTABLECis Bio International
- BelgiumGallium [Ga-67]-citraat Curium 37 MBq/mlCurium Belgium
- IrelandGallium (Ga67) Citrate injectionCurium Netherlands B.V.
- Japanクエン酸ガリウム(67Ga)
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Belgium · Gallium [ga-67] Citrate Curium, Gallium [ga-67]-Citraat Curium
- Czechia · Gallium (Ga67) Citrate Curium Netherlands
- Denmark · Gallium Ga67 Citrate Curium Netherlands
- Spain · Citrato De Galio (67ga) Cis Bio International, Citrato De Galio (67ga) Curium Pharma Spain
- France · Citrate De Gallium (67ga) Cis Bio International, Citrate De Gallium (67ga) Curiumpharma
- United Kingdom (Northern Ireland) · Gallium (Ga67) Citrate Curium Netherlands
- Greece · Gallium (67ga) Citrate Curium Netherlands
- Hungary · [67ga]-Gallium-Citrát Curiumpharma
- Ireland · Gallium (Ga67) Citrate Curium Netherlands
- Italy · Gallio (67ga) Citrato Curium Netherlands
- Netherlands · Gallium (Ga 67) Citrate Curium Netherlands
- Portugal · Citrato De Gálio (67ga) Cis Bio International, Citrato De Gálio (67ga) Curium Netherlands
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/10683fc6-dd65-4aec-88c8-02b93edc2e65 GET /v1/drugs/10683fc6-dd65-4aec-88c8-02b93edc2e65?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02327813",
"form": "SOLUTION",
"class": "Radiopharmaceutical",
"routes": [
"INTRAVENOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "V09HX01",
"schedule": [
"Schedule C"
],
"drug_code": "81328",
"strengths": [
"74 MBq"
],
"ahfs_class": null,
"substances": [
"GALLIUM CITRATE GA 67"
],
"product_categorization": null
}See everything about gallium (67ga) citrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.